Quick Answer
IOVANCE BIOTHERAPEUTICS, INC. reported Total Revenue of $263.50 million for fiscal year 2025.
IOVANCE BIOTHERAPEUTICS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $263.50M | +60.6% |
| 2024 | $164.07M | +13699.0% |
| 2023 | $1.19M | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
| 2012 | $0.00 | — |
| 2011 | $0.00 | — |
| 2010 | $0.00 | — |
| 2009 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $67.45M | +15.2% | +12.5% |
| June 30, 2025 | $59.95M | +92.7% | +21.5% |
| March 31, 2025 | $49.32M | +6798.5% | -15.8% |
| September 30, 2024 | $58.55M | +12385.1% | +88.2% |
| June 30, 2024 | $31.11M | +12969.7% | +4250.5% |
| March 31, 2024 | $715.0K | — | +52.5% |
| September 30, 2023 | $469.0K | — | +97.1% |
| June 30, 2023 | $238.0K | — | — |
- IOVANCE BIOTHERAPEUTICS, INC. showed an increase of +60.6% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from IOVANCE BIOTHERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: